Carlos Andres Aude

Johns Hopkins University

United States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (4)

Stinne Greisen

Aarhus University

Susan M Goodman

Hospital for Special Surgery

UNITED STATES

Ami A. Shah

UNITED STATES

Jeffrey Sparks

Associate Physician/Associate Professor of Medicine

Brigham and Women's Hospital

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carlos Andres Aude

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (4)

Stinne Greisen

Susan M Goodman

Ami A. Shah

Jeffrey Sparks

Make your next move.

Carlos Andres Aude

Research Interests

Explore related searches

Contact this professor

Articles (10)

Machine Learning Reveals Demographic Disparities in Palliative Care Timing Among Patients With Traumatic Brain Injury Receiving Neurosurgical Consultation

Temporal Trends in the Rate of Revision Total Knee Arthroplasty for Prosthetic Joint Infection

Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 ‘shared epitope’ are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis

Clonally expanded CD38 hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis

Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis

Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis

AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY

COMPARATIVE SAFETY AND EFFECTIVENESS OF TNF INHIBITORS, IL6R INHIBITORS AND METHOTREXATE FOR THE TREATMENT OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED ARTHRITIS

EACHTHEIR OWN- CLASSIFICATION OF ARTHRITIS PHENOTYPE AMONG INFLAMMATORY ARTHRITIS PATIENTS WITH CANCERTREATED WITH IMMUNE CHECKPOINT INHIBITORS

USING SURVIVAL CLASSIFICATION AND REGRESSION TREES AND SURVIVAL RANDOM FOREST TO INVESTIGATE ASSOCIATIONS AMONG FACTORS FOR CANCER PROGRESSION AND ARTHRITIS CONTROL IN A MULTI-CENTER RETROSPECTIVE COHORT OF PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR ASSOCIATED INFLAMMATORY ARTHRITIS

Collaborators (4)

Stinne Greisen

Susan M Goodman

Ami A. Shah

Jeffrey Sparks

Make your next move.